Posted inBusiness Insights
Jubilant Pharmova Subsidiary Secures Tentative USFDA Nod for Pantoprazole Oral Suspension
Jubilant Generics' tentative USFDA approval for Pantoprazole Oral Suspension marks a key milestone, paving the way for future market entry in 2026.
